• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tc 焦磷酸盐(PYP)平面定量和半定量参数成像诊断转甲状腺素蛋白(ATTR)心脏淀粉样变的诊断性能特征:SCAN-MP 研究。

Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study.

机构信息

Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.

Section of Cardiology, Department of Medicine, Boston University School of Medicine, 72 East Concord Street, C-8, Boston, MA, 02118, USA.

出版信息

J Nucl Cardiol. 2023 Aug;30(4):1414-1419. doi: 10.1007/s12350-023-03203-9. Epub 2023 Feb 23.

DOI:10.1007/s12350-023-03203-9
PMID:36823486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11268194/
Abstract

BACKGROUND

The optimal heart-to-contralateral chest (H/CL) ratio threshold for non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) using Tc pyrophosphate (PYP) imaging in a population with low pretest probability is not known.

METHODS

Using myocardial PYP retention by SPECT as the reference standard, we evaluated the diagnostic performance of different semi-quantitative and quantitative (H/CL chest ratio) planar parameters obtained from 3-hour PYP imaging in a prospectively recruited cohort of minority older adults with heart failure and increased LV wall thickness.

RESULTS

Of 229 patients, 14 were found to have ATTR-CA (6.1%). No PYP uptake (grade 0) was observed in 77% of scans, all grade 3 scans were ATTR-CA, and only 4 of 11 (36%) grade 2 scans were ATTR-CA. An H/CL threshold of ≥ 1.4 maximized specificity (99%) and positive predictive value (93%) but resulted in decreased sensitivity (93%), compared to the ≥ 1.3 threshold which had 100% sensitivity.

CONCLUSION

Among patients with a low pretest likelihood of ATTR-CA, planar interpretation, while useful to exclude disease, must be interpreted with caution. H/CL ratio threshold of ≥ 1.3 resulted in clinically important misclassifications. These data suggest that quantitative planar imaging thresholds may not be appropriate to apply in low pretest likelihood populations being evaluated for ATTR-CA.

摘要

背景

使用 Tc 焦磷酸盐(PYP)成像对低术前概率人群进行转甲状腺素蛋白心脏淀粉样变性(ATTR-CA)的无创诊断时,最佳的心脏与对侧胸部(H/CL)比值阈值尚不清楚。

方法

我们使用 SPECT 心肌 PYP 保留作为参考标准,评估了 3 小时 PYP 成像中不同半定量和定量(H/CL 胸部比值)平面参数在具有心力衰竭和左心室壁增厚增加的少数族裔老年患者前瞻性招募队列中的诊断性能。

结果

在 229 名患者中,发现 14 名患有 ATTR-CA(6.1%)。77%的扫描未见 PYP 摄取(等级 0),所有等级 3 的扫描均为 ATTR-CA,而仅 11 个等级 2 的扫描中的 4 个(36%)为 ATTR-CA。H/CL 阈值≥1.4 可最大程度提高特异性(99%)和阳性预测值(93%),但敏感性降低(93%),而阈值≥1.3 具有 100%的敏感性。

结论

在术前 ATTR-CA 可能性较低的患者中,平面解释虽然有助于排除疾病,但必须谨慎解释。H/CL 比值阈值≥1.3 会导致临床上重要的错误分类。这些数据表明,定量平面成像阈值可能不适用于评估 ATTR-CA 的低术前可能性人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/11268194/5ff0ce841bf3/nihms-2007486-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/11268194/5ff0ce841bf3/nihms-2007486-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/11268194/5ff0ce841bf3/nihms-2007486-f0001.jpg

相似文献

1
Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study.Tc 焦磷酸盐(PYP)平面定量和半定量参数成像诊断转甲状腺素蛋白(ATTR)心脏淀粉样变的诊断性能特征:SCAN-MP 研究。
J Nucl Cardiol. 2023 Aug;30(4):1414-1419. doi: 10.1007/s12350-023-03203-9. Epub 2023 Feb 23.
2
Inter-observer reproducibility and intra-observer repeatability in Tc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis.三价焦磷酸盐扫描解读诊断转甲状腺素蛋白心脏淀粉样变性的观察者间重现性和观察者内可重复性。
J Nucl Cardiol. 2022 Apr;29(2):440-446. doi: 10.1007/s12350-020-02353-4. Epub 2020 Sep 11.
3
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术:预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
4
Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow.迈向心脏淀粉样变性诊断:焦磷酸盐锝 99m 核素平面显像的单中心经验及诊断工作流程标准化的机遇。
Medicina (Kaunas). 2023 Feb 16;59(2):378. doi: 10.3390/medicina59020378.
5
Comparison of 1-h with 3-h planar Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.用 SPECT 作为参考标准比较 1 小时与 3 小时平面 Tc-焦磷酸盐闪烁显像在疑似转甲状腺素蛋白心脏淀粉样变性患者中的应用。
Ann Nucl Med. 2023 Feb;37(2):99-107. doi: 10.1007/s12149-022-01807-8. Epub 2022 Nov 10.
6
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
7
Serial scanning with technetium pyrophosphate (Tc-PYP) in advanced ATTR cardiac amyloidosis.在晚期转甲状腺素蛋白淀粉样变心肌病中使用焦磷酸锝(Tc-PYP)进行连续扫描。
J Nucl Cardiol. 2016 Dec;23(6):1355-1363. doi: 10.1007/s12350-015-0261-x. Epub 2015 Oct 9.
8
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.在 SCAN-MP 研究中:前 379 例,焦磷酸盐显像上心外摄取的发生率和意义。
J Nucl Cardiol. 2023 Dec;30(6):2531-2539. doi: 10.1007/s12350-023-03310-7. Epub 2023 Jun 13.
9
Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.疑似心脏淀粉样变性患者的锝-99m焦磷酸钠/铊-201双同位素同时心肌单光子发射计算机断层显像
J Nucl Cardiol. 2020 Feb;27(1):28-37. doi: 10.1007/s12350-019-01753-5. Epub 2019 Jun 6.
10
Volumetric evaluation of Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.Tc-焦磷酸盐 SPECT/CT 对转甲状腺素蛋白心脏淀粉样变性的容积评估:方法学及与心脏功能参数的相关性。
J Nucl Cardiol. 2022 Dec;29(6):3102-3110. doi: 10.1007/s12350-021-02857-7. Epub 2021 Dec 14.

引用本文的文献

1
Lateral Planar Imaging of Tc-pyrophosphate Scintigraphy in Patients with Suspected Transthyretin Cardiac Amyloidosis.疑似转甲状腺素蛋白心脏淀粉样变性患者的Tc-焦磷酸盐闪烁扫描术的平面侧位成像
Ann Nucl Cardiol. 2024;10(1):29-37. doi: 10.17996/anc.24-00002. Epub 2024 Oct 31.
2
Optimizing cardiac amyloidosis assessment: utility of 1-h and 3-h Tc-PYP imaging.优化心脏淀粉样变性评估:1 h 和 3 h Tc-PYP 成像的应用。
Eur J Med Res. 2024 Jan 6;29(1):32. doi: 10.1186/s40001-023-01629-y.

本文引用的文献

1
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.美国核医学与分子影像学会/美国心脏协会/美国超声心动图学会/欧洲核医学协会/美国心力衰竭学会/美国心律学会/心血管磁共振学会/美国核医学与分子影像学会心脏淀粉样变性多模态成像专家共识建议:第2部分,共2部分 - 诊断标准与合理应用
Circ Cardiovasc Imaging. 2021 Jul;14(7):e000030. doi: 10.1161/HCI.0000000000000030. Epub 2021 Jul 1.
2
False Positive 99mTc-Pyrophosphate Scanning Leading to Inappropriate Tafamidis Prescriptions.99m锝焦磷酸盐扫描假阳性导致不合适的塔非酰胺处方。
JACC Cardiovasc Imaging. 2021 Oct;14(10):2042-2044. doi: 10.1016/j.jcmg.2021.04.006. Epub 2021 May 19.
3
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
4
Absolute Quantitation of Cardiac Tc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT.基于碲化镉锌的 SPECT/CT 进行心脏 Tc-焦磷酸盐的绝对定量
J Nucl Med. 2021 May 10;62(5):716-722. doi: 10.2967/jnumed.120.247312. Epub 2020 Sep 4.
5
DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.心肌淀粉样变中 DPD 的定量:一种新型的影像学生物标志物。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1353-1363. doi: 10.1016/j.jcmg.2020.03.020.
6
Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis.高效 1 小时 99mTc 焦磷酸盐成像方案诊断转甲状腺素蛋白心脏淀粉样变。
Circ Cardiovasc Imaging. 2020 Feb;13(2):e010249. doi: 10.1161/CIRCIMAGING.119.010249. Epub 2020 Feb 17.
7
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.
8
Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population.转甲状腺素蛋白心脏淀粉样变中锝-亚甲基二膦酸盐定量单光子发射计算机断层扫描/计算机断层扫描及非患病人群心肌摄取参考区间的建立。
Eur J Hybrid Imaging. 2018;2(1):17. doi: 10.1186/s41824-018-0035-1. Epub 2018 Aug 22.
9
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术:预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
10
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.